Publications
Filters: Keyword is Child, Preschool [Clear All Filters]
“Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children”, Nat Commun, vol. 10, no. 1, p. 480, 2019.
, “Spatiotemporal epidemiology, environmental correlates, and demography of malaria in Tak Province, Thailand (2012-2015)”, Malar J, vol. 18, no. 1, p. 240, 2019.
, “Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border”, J Infect Dis, vol. 215, no. 3, pp. 396-404, 2017.
, “Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?”, Expert Opin Drug Saf, vol. 15, no. 3, pp. 367-82, 2016.
, ,
“Pyronaridine-artesunate versus mefloquine plus artesunate for malaria”, N Engl J Med, vol. 366, no. 14, pp. 1298-309, 2012.
, “Barriers to immunization among children of migrant workers from Myanmar living in Tak province, Thailand”, Bull World Health Organ, vol. 89, no. 7, pp. 528-31, 2011.
, , ,
“Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar”, Trop Med Int Health, vol. 13, no. 1, pp. 91-8, 2008.
, “A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia”, Trop Med Int Health, vol. 12, no. 2, pp. 251-9, 2007.
, “Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison”, Lancet, vol. 367, no. 9528, pp. 2075-85, 2006.
, “Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria”, Antimicrob Agents Chemother, vol. 50, no. 7, pp. 2281-5, 2006.
, “Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial”, Lancet, vol. 366, no. 9487, pp. 717-25, 2005.
, “Artesunate combinations for treatment of malaria: meta-analysis”, Lancet, vol. 363, no. 9402. pp. 9-17, 2004.
, “Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens”, Trans R Soc Trop Med Hyg, vol. 98, no. 3, pp. 182-92, 2004.
, “The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos”, Ann Trop Med Parasitol, vol. 96, no. 6, pp. 553-7, 2002.
, “Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil”, Clinical Infectious Diseases, vol. 35, no. 12, pp. 1498-504., 2002.
, “Factors contributing to anemia after uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614-22., 2001.
, “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545-8., 2000.
, “A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 65-9, 2000.
, “Plasmodium falciparum antimalarial drug susceptibility on the north- western border of Thailand during five years of extensive use of artesunate-mefloquine”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 537-44., 2000.
, “Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 936-42, 1999.
, “Genetic analysis of Plasmodium falciparum infections on the north- western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 587-93, 1999.
, “No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 61, no. 6, pp. 964-7, 1999.
, “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria”, Antimicrob Agents Chemother, vol. 43, no. 2, pp. 341-6, 1999.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “Treatment of vivax malaria on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 433-8, 1999.
, “Artesunate and mefloquine in the treatment of uncomplicated multidrug- resistant hyperparasitaemic falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 207-11, 1998.
, “Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 6, pp. 883-8, 1998.
, “Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 45-9, 1998.
, “Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 562-3, 1998.
, “Two patients with falciparum malaria and poor in vivo responses to artesunate”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 6, pp. 668-9, 1998.
, “Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 574-7, 1997.
, “The epidemiology of severe malaria in an area of low transmission in Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 256-62, 1997.
, “Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia”, Am J Trop Med Hyg, vol. 56, no. 5, pp. 526-32, 1997.
, “Effects of artemisinin derivatives on malaria transmissibility”, Lancet, vol. 347, pp. 1654-8, 1996.
, “Electrocardiographic monitoring in severe falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 3. pp. 266-9, 1996.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand.”, Lancet, vol. 348, pp. 701-7, 1996.
, “Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 5, pp. 523-7, 1995.
, “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
, “Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study”, PARASITOLOGY, vol. 110, no. Suppl. pp. S25-36, 1995.
, “Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients”, Bulletin of the World Health Organization, vol. 73, no. 5, pp. 631-42, 1995.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
, “Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 6, pp. 660-4, 1995.
, “Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography”, American Journal of Tropical Medicine and Hygiene, vol. 51, no. 6, pp. 778-84, 1994.
, “Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 1. pp. 67-73, 1994.
, “Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 2, pp. 213-7, 1994.
, “Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria”, Lancet, vol. 341, pp. 1044-9, 1993.
, “Absorption of intramuscular phenobarbitone in children with severe falciparum malaria”, European Journal of Clinical Pharmacology, vol. 42, no. 1. pp. 107-10, 1992.
, “Comparison of artemether and chloroquine for severe malaria in Gambian children”, Lancet, vol. 339, pp. 317-21, 1992.
, “High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria”, Journal of Infectious Diseases, vol. 166, no. 6, pp. 1393-400, 1992.
, “Intracranial pressure in childhood cerebral malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 3, pp. 362-4, 1991.
, “Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria”, British Journal of Clinical Pharmacology, vol. 31, no. 5, pp. 556-9, 1991.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
,